Errata (DOI:10.1016/S1474-4422(08)70119-4);Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial

The Lancet Neurology

Volumn 7, Issue 8, 2008, Pages 690-695

  Ljøstad, Unn ^a   Skogvoll, Eirik ^b   Eikeland, Randi ^c   Midgard, Rune ^d   Skarpaas, Tone ^a   Berg, Åse ^e   Mygland, Åse ^a,f,g  

^a Sørlandet Hospital Hf   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c Sørlandet Hospital   (Norway)

^d Molde Hospital   (Norway)

^e STAVANGER UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF BERGEN   (Norway)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BACTERIUM ANTIBODY; CEFTRIAXONE; DOXYCYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ACRODERMATITIS CHRONICA ATROPHICANS; ADULT; ALLERGY; ARTICLE; BORRELIA BURGDORFERI; CEREBROSPINAL FLUID; CHOLECYSTITIS; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; DUODENUM ULCER; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE COUNT; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NEUROLOGIC EXAMINATION; NORWAY; PRIORITY JOURNAL; PROCTITIS; RANDOMIZED CONTROLLED TRIAL; RASH; SCORING SYSTEM; STOMATITIS; STRUCTURED INTERVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 46849111834     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(08)70153-4     Document Type: Erratum

References (28)

1. Halperin J., Shapiro E., Logigian E., et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 69 (2007) 91-102
2. Cunha B. Intravenous-to-oral antibiotic switch therapy. A cost-effective approach. Postgrad Med 101 (1997) 111-122
3. Hunfeld K., and Brade V. Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know. Wien Klin Wochenschr 118 (2006) 659-668
4. Karlsson M., Hammers S., Nilsson-Ehle I., Malmborg A., and Wretlind B. Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis. Antimicrob Agents Chemother 40 (1996) 1104-1107
5. Ogrinc K., Logar M., Lotric-Furlan S., Cerar D., Ruzic-Sabljic E., and Strle F. Doxycycline versus ceftriaxone for the treatment of patients with chronic Lyme borreliosis. Wien Klin Wochenschr 118 (2006) 696-701
6. Kohlhepp W., Oschmann P., and Mertens H. Treatment of Lyme borreliosis. Randomized comparison of doxycycline and penicillin G. J Neurol 236 (1989) 464-469
7. Karlsson M., Hammers-Berggren S., Lindquist L., Stiernstedt G., and Svenungsson B. Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology 44 (1994) 1203-1207
8. Karkkonen K., Stiernstedt S., and Karlsson M. Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis. Scand J Infect Dis 33 (2001) 259-262
9. Dotevall L., and Hagberg L. Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infect Dis 28 (1999) 569-574
10. Borg R., Dotevall L., Hagberg L., et al. Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis. Scand J Infect Dis 37 (2005) 449-454
11. Halperin J., Logigian E., Finkel M., and Pearl R. Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology. Neurology 46 (1996) 619-627
12. Stanek G., O'Connell S., Cimmino M., et al. European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 108 (1996) 741-747
13. Ljostad U., Skarpaas T., and Mygland A. Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis. Eur J Neurol 14 (2007) 873-876
14. Hansen K., and Lebech A. Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi-specific immunoglobulin G, A, and M. Ann Neurol 30 (1991) 197-205
15. Machin D., Campbell M., Fayers P., and Pinol A. Sample size tables for clinical studies (1997), Blackwell Science, Oxford
16. Blackwelder W. "Proving the null hypothesis" in clinical trials. Control Clin Trials 3 (1982) 345-353
17. Berglund J., Stjernberg L., Ornstein K., Tykesson-Joelsson K., and Walter H. 5-y follow-up study of patients with neuroborreliosis. Scand J Infect Dis 34 (2002) 421-425
18. Ljostad U., Mygland A., and Skarpaas T. [Neuroborreliosis in Vest-Agder]. Tidsskr Nor Laegeforen 123 (2003) 610-613
19. Vrethem M., Hellblom L., Widlund M., et al. Chronic symptoms are common in patients with neuroborreliosis-a questionnaire follow-up study. Acta Neurol Scand 106 (2002) 205-208
20. Dattwyler R., Wormser G., Rush T., et al. A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wien Klin Wochenschr 117 (2005) 393-397
21. Oksi J., Nikoskelainen J., Hiekkanen H., et al. Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study. Eur J Clin Microbiol Infect Dis 26 (2007) 571-581
22. Klempner M., Hu L., Evans J., et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 345 (2001) 85-92
23. Krupp L., Hyman L., Grimson R., et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 60 (2003) 1923-1930
24. Fallon B., Keilp J., Corbera K., et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 70 (2008) 992-1003
25. Strle F., Ruzic-Sabljic E., Cimperman J., Lotric-Furlan S., and Maraspin V. Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid. Clin Infect Dis 43 (2006) 704-710
26. Sicklinger M., Wienecke R., and Neubert U. In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto. J Clin Microbiol 41 (2003) 1791-1793
27. Steere A. Lyme disease. N Engl J Med 345 (2001) 115-125
28. Bland J., and Altman D. Statistics notes: validating scales and indexes. BMJ 324 (2002) 606-607